Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Label Phase II Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization

NCT01037517 is registered in ClinicalTrials.gov with CancerCare Manitoba as lead sponsor.

NCT NCT01037517
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01037517 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Label Phase II Trial of an Augmented Mobilization Strategy With Plerixafor (Mozobil®) in a Population at Risk for Poor Stem Cell Mobilization
Lead sponsor
CancerCare Manitoba
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2010
Completion date
August 31, 2013
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, multiple myeloma